Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Not applicable Clear all

1,466 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20024
20035
20044
200516
200621
200722
200827
200931
201032
201147
201245
201360
201472
201558
201671
201768
201889
2019113
202073
202199
202292
202396
2024107
2025103
202687

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed921
Unknown status148
Recruiting147
Terminated69
Not yet recruiting64
Active, not recruiting56
Withdrawn42
Enrolling by invitation12
Suspended7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Virginia56
Medtronic MiniMed, Inc.45
Rabin Medical Center28
Steno Diabetes Center Copenhagen26
University of Colorado, Denver24
Yale University23
Stanford University20
Nemours Children's Clinic18
University of Aarhus18
Institut de Recherches Cliniques de Montreal17

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 11,466
Diabetes Mellitus204
Diabetes Mellitus, Type 2156
Hypoglycemia123
Insulin Resistance57
Hyperglycemia33
Endocrine System Diseases18
Glucose Metabolism Disorders16
Autoimmune Diseases15
Obesity15

Trials

Showing 76 to 100 of 1,466. Each trial links to its page on Pharma Observatory.

1,366 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.